eFFECTOR Therapeutics, Inc.
EFTRDelisted Jul 19, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828522
eFFECTOR Therapeutics, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $251.1K in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding eFFECTOR Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 12 | 18 | +6 |
| Shares | 13.4M | 21.4M | +7.97M (+59.4%) |
| Value | $187.9M | $174.2M | −$13.8M (−7.3%) |
New holders (11)
Institutions that held eFFECTOR Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sr One Capital Management, LP | 6,822,114 | $56.5M | 31.92% |
| OUP Management Co., LLC | 1,025,697 | $8.49M | 3.83% |
| Vanguard Group Inc | 516,164 | $4.27M | 0.00% |
| Alps Advisors Inc | 51,942 | $430.0K | 0.00% |
| Northern Trust Corp | 16,657 | $138.0K | 0.00% |
| Two Sigma Investments, LP | 14,122 | $117.0K | 0.00% |
| Penserra Capital Management LLC | 3,003 | $24.0K | 0.00% |
| UBS Group AG | 2,401 | $20.0K | 0.00% |
| BlackRock Inc. | 1,133 | $10.0K | 0.00% |
| JPMorgan Chase & Co | 780 | $6.00K | 0.00% |
| Wells Fargo & Company | 59 | $0 | 0.00% |
Sold out (5)
Institutions that held eFFECTOR Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Verition Fund Management LLC | 24,667 | $347.0K |
| Jane Street Group, LLC | 18,304 | $257.0K |
| Virtu Financial LLC | 17,444 | $245.0K |
| Citadel Advisors LLC | 13,277 | $187.0K |
| Creative Financial Designs Inc | 430 | $6.00K |